SOUTH SAN FRANCISCO, Calif., Nov. 25, 2020 (GLOBE NEWSWIRE) — CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced that the Company will participate in the upcoming Piper Sandler 32nd Annual Virtual Healthcare Conference.
Conference Dates: Tuesday, December 1 to Thursday, December 3, 2020. A link to the fireside chat presentation is available on the “Investors” section of the Company’s website at investors.caredxinc.com.
About CareDx
CareDx, Inc., headquartered in South San Francisco, California, is a leading precision medicine solutions company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey, and is the leading provider of genomics-based information for transplant patients. For more information, please visit: www.CareDx.com.
CONTACT:
Investor Relations
Greg Chodaczek
347-610-7010
investor@caredx.com
MINNEAPOLIS, Dec. 22, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical…
-Four autoimmune patients treated to date demonstrate deep B-cell depletion sustained for at least 28…
Patient achieved complete remission and well-tolerated safety profile, advancing path to Phase 2BOSTON, Dec. 22,…
Kennewick, WA, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL) The IsoPet division…
U.S. Naloxone Market: ~$154 million in annual sales and 9.3 million units annually COMMACK, NY,…
HOUSTON, Dec. 22, 2025 (GLOBE NEWSWIRE) -- CoRegen, Inc., a biopharmaceutical company pursuing novel treatments…